tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Balance Sheet

Compare
140 Followers

SAB Biotherapeutics Balance Sheet

SAB Biotherapeutics's total assets for Q4 2024 were $44.20M, a decrease of -17.85% from the previous quarter. SABS total liabilities were $18.23M for the fiscal quarter, a 7.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 44.20M$ 83.94M$ 50.90M$ 79.37M$ 56.54M
Total Liabilities
$ 18.23M$ 26.64M$ 19.85M$ 40.82M$ 17.53M
Total Equity Gross Minority
$ 25.97M$ 57.30M$ 31.06M$ 38.55M$ 39.01M
Other Metrics
Currency in USD

SAB Biotherapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis